Acute Kidney Disease Diagnosis and Management

Introduction to Acute Kidney Disease

The Kidney Disease: Improving Global Outcomes (KDIGO) criteria for acute kidney injury (AKI) requires a ≥50% rise in creatinine within 7 days or a ≥0.3 mg/dL rise within 48 hours, which is not met by a 99% increase over 2 months, but still indicates significant kidney function decline 1, 2
A creatinine rise from 0.8 to 1.59 mg/dL over 2 months represents a significant decline in kidney function, suggesting acute kidney disease (AKD) rather than AKI, given the time course exceeds 7 days but is less than 3 months 1

Prerenal causes account for 27-50% of kidney injury cases and should be evaluated first, including volume depletion, cardiac dysfunction, and hypotension 3
Medication-induced causes are critical to review, as they are reversible, including ACE inhibitors, NSAIDs, diuretics, and calcineurin inhibitors 4, 3, 5
Intrinsic renal causes account for 14-35% of cases, indicating kidney parenchymal damage, and include acute tubular necrosis (ATN), acute interstitial nephritis, and glomerulonephritis 3, 2, 5
Postrenal causes, although rare (<3% of cases), must be excluded early and include urinary tract obstruction 2

Urinalysis with microscopy is essential to check for proteinuria, hematuria, and casts, which can indicate glomerular disease, glomerulonephritis, or ATN 3, 2
Serum electrolytes should be checked for hyperkalemia and hyponatremia, and a complete blood count can assess for anemia, suggesting a chronic process 3, 2
Renal ultrasound is the first-line imaging to exclude obstruction, assess kidney size, and evaluate for hydronephrosis 2

If prerenal, discontinue or reduce diuretics, and consider volume repletion with IV albumin or isotonic saline, and reassess creatinine in 48-72 hours 3, 4
If medication-related, discontinue the offending agent, such as NSAIDs, and expect improvement in creatinine levels 3, 4
If intrinsic renal disease is suspected, consider nephrology referral and renal biopsy if diagnosis would change management 3, 2, 5
If postrenal, urgent urology consultation is necessary for relief of obstruction, which should result in rapid improvement in creatinine 2

Oliguria (<0.5 mL/kg/h for >6 hours) indicates Stage 1 AKI or worse, and requires urgent action 1, 6
Hyperkalemia (>5.6 mmol/L) poses a risk of cardiac arrhythmias, especially with ACE inhibitors 4
Severe hypertension or hypotension may indicate hypertensive emergency or cardiorenal syndrome, and requires immediate attention 4
Uremic symptoms, such as nausea, vomiting, altered mental status, and pericarditis, necessitate prompt intervention 2
A creatinine level >4.0 mg/dL with an acute rise meets Stage 3 AKI criteria and may require dialysis 1, 3

The American Society of Clinical Oncology (ASCO) and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend hospitalization for patients with creatinine ≥4.0 mg/dL, as it meets KDIGO Stage 3 AKI criteria, which mandates hospitalization 7, 8
The KDIGO guideline states that for G3 creatinine elevation, "hospitalization indicated" is part of the staging definition itself, not merely a suggestion, emphasizing the need for close monitoring and potential intervention 7
Patients with Stage 3 AKI may require renal replacement therapy, which necessitates inpatient monitoring and nephrology consultation 7
Mandatory nephrology consultation is required for all patients with creatinine ≥4.0 mg/dL or Stage 3 AKI, to evaluate the need for renal replacement therapy and guide immunosuppression if immune-mediated 7
Nephrology should assess the patient's volume status, and if prerenal azotemia is suspected, consider volume repletion with isotonic crystalloids rather than colloids 9
Corticosteroids (1-2 mg/kg/day prednisone equivalent) may be considered if immune-mediated nephritis is suspected after excluding other causes 7
Daily or twice-daily creatinine and electrolyte monitoring is necessary for patients with Stage 3 AKI 7
The American Heart Association, as published in Circulation, recommends careful risk-benefit assessment before continuing ACE inhibitors/ARBs in patients with creatinine >2.5 mg/dL in men or >2.0 mg/dL in women 10

Discontinuation of nephrotoxic medications, particularly NSAIDs and potentially ACE inhibitors/ARBs, is recommended depending on clinical context, although specific guidance is not provided in the cited references
Assessment of volume status and consideration of volume repletion with isotonic crystalloids is necessary for patients with prerenal azotemia 9
The American Journal of Kidney Diseases commentary explicitly warns against stage-based protocolization but acknowledges that Stage 3 AKI requires intensive monitoring that cannot be provided outpatient 11

The KDIGO commentary emphasizes the importance of individualized care and warns against stage-based protocolization, but acknowledges the need for hospitalization and close monitoring for patients with Stage 3 AKI 11
The ASCO/KDIGO guidelines recommend hospitalization and mandatory nephrology consultation for patients with creatinine ≥4.0 mg/dL or Stage 3 AKI 7

The American Heart Association recommends careful risk-benefit assessment before continuing ACE inhibitors or ARBs when creatinine exceeds 2.5 mg/dL in men or 2.0 mg/dL in women, and discontinuation is recommended if creatinine rise is >0.5 mg/dL when baseline creatinine is <2.0 mg/dL (or >1.0 mg/dL when baseline exceeds 2.0 mg/dL) 12, 13
ACE inhibitor-associated acute renal failure is almost always reversible, with improvement typically occurring within 2-3 days of cessation, and substitution with ARBs is not recommended as they exert identical effects on renal hemodynamics 12, 13
NSAIDs potentiate or independently initiate acute renal failure episodes, especially in the setting of ACE inhibitor therapy, and patients must be educated to avoid NSAIDs during recovery 12
Overly aggressive diuresis is a common precipitant of acute renal failure in patients on ACE inhibitors, and volume depletion tips the renal hemodynamic balance, making GFR maintenance dependent on angiotensin II 12, 13
Small to moderate elevations in creatinine during diuresis may be acceptable if volume overload is present, with an acceptable increase of up to 30% if achieving euvolemia 14

Cardiac dysfunction with reduced cardiac output is a prerenal cause of acute kidney injury 12

In adults, urine output < 0.5 mL/kg/h for ≥ 6 hours defines Stage 1 AKI, while urine output < 0.3 mL/kg/h for ≥ 24 hours or anuria for ≥ 12 hours defines Stage 3 AKI. [15][16]

An oliguria of ≈ 100 mL/24 h (≈ 0.07 mL/kg/h for a 70‑kg adult) is linked to a markedly higher in‑hospital mortality compared with AKI identified solely by serum‑creatinine rise. 16

In patients with cirrhosis and ascites, urine output is a less reliable indicator of AKI because of intense sodium retention; however, in non‑cirrhotic contexts, oliguria of the magnitude described remains a strong predictor of adverse outcomes. [15][16]17

For cirrhotic patients who develop AKI, discontinuation of diuretics combined with intravenous albumin infusion for volume expansion is recommended to improve renal perfusion and mitigate creatinine rise. 16